DK1351907T3 - 2-Butyl - 3 - (4-(3-dibutylamino) propoxy) -5- nitrobenzofuranchlorhydrat og fremstilling heraf - Google Patents
2-Butyl - 3 - (4-(3-dibutylamino) propoxy) -5- nitrobenzofuranchlorhydrat og fremstilling herafInfo
- Publication number
- DK1351907T3 DK1351907T3 DK01270513T DK01270513T DK1351907T3 DK 1351907 T3 DK1351907 T3 DK 1351907T3 DK 01270513 T DK01270513 T DK 01270513T DK 01270513 T DK01270513 T DK 01270513T DK 1351907 T3 DK1351907 T3 DK 1351907T3
- Authority
- DK
- Denmark
- Prior art keywords
- nitrobenzofuran
- chlorohydrate
- dibutylamino
- propoxy
- butyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D307/80—Radicals substituted by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
- C07C217/14—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring
- C07C217/18—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
- C07C217/22—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by carbon atoms having at least two bonds to oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0016069A FR2817865B1 (fr) | 2000-12-11 | 2000-12-11 | Derive aminoalkoxybenzoyle sous forme de sel, son procede de preparation et son utilisation comme intermediaire de synthese |
PCT/FR2001/003900 WO2002048078A1 (fr) | 2000-12-11 | 2001-12-10 | Chlorhydrate du 2-butyl-3-(4-'3-(dibutylamino)propoxy!benzoyl)-5-nitro-benzofurane et sa preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1351907T3 true DK1351907T3 (da) | 2007-03-26 |
Family
ID=8857481
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK01270513T DK1351907T3 (da) | 2000-12-11 | 2001-12-10 | 2-Butyl - 3 - (4-(3-dibutylamino) propoxy) -5- nitrobenzofuranchlorhydrat og fremstilling heraf |
Country Status (21)
Country | Link |
---|---|
US (1) | US6846936B2 (cs) |
EP (1) | EP1351907B1 (cs) |
JP (2) | JP4437004B2 (cs) |
CN (2) | CN100371314C (cs) |
AR (1) | AR035663A1 (cs) |
AT (1) | ATE345319T1 (cs) |
AU (1) | AU2002217227A1 (cs) |
BR (1) | BR0116065B1 (cs) |
CA (1) | CA2429268C (cs) |
CZ (1) | CZ303489B6 (cs) |
DE (1) | DE60124587T2 (cs) |
DK (1) | DK1351907T3 (cs) |
ES (1) | ES2276741T3 (cs) |
FR (1) | FR2817865B1 (cs) |
HK (1) | HK1055944A1 (cs) |
HR (1) | HRP20030471B1 (cs) |
HU (1) | HUP0500981A3 (cs) |
MX (1) | MXPA03005223A (cs) |
PL (1) | PL206029B1 (cs) |
SK (1) | SK287770B6 (cs) |
WO (1) | WO2002048078A1 (cs) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI356054B (en) * | 2004-03-31 | 2012-01-11 | Activus Pharma Co Ltd | Quaternary ammonium compound, producing method the |
GB0719180D0 (en) | 2007-10-02 | 2007-11-14 | Cambrex Karlskoga Ab | New process |
NZ588623A (en) * | 2008-04-17 | 2012-11-30 | Sanofi Aventis | Use of a medicament containing dronedarone with food for preventing cardiovascular hospitalization |
FR2930149B1 (fr) * | 2008-04-17 | 2011-02-18 | Sanofi Aventis | Association de dronedarone avec au moins un diuretique, son application en therapeutique |
EP2116239A1 (en) * | 2008-04-29 | 2009-11-11 | Sanofi-Aventis | Method for managing the risks associated with an increase in serum creatinine during dronedarone treatment |
EP2246341A1 (en) | 2009-01-23 | 2010-11-03 | Lonza Ltd. | Process for preparing 2-Alkyl-3-aroyl-5-nitro-benzofurans |
US20120122971A1 (en) * | 2009-04-08 | 2012-05-17 | Cambrex Karlskoga Ab | New process for preparing hydroxylamines and medicaments |
TW201111354A (en) | 2009-05-27 | 2011-04-01 | Sanofi Aventis | Process for the production of Dronedarone intermediates |
TW201107303A (en) | 2009-05-27 | 2011-03-01 | Sanofi Aventis | Process for the production of benzofurans |
CN101993427B (zh) * | 2009-08-26 | 2012-10-10 | 成都伊诺达博医药科技有限公司 | 一种制备决奈达隆的方法 |
HUP0900759A2 (en) | 2009-12-08 | 2011-11-28 | Sanofi Aventis | Novel process for producing dronedarone |
HUP1000010A2 (en) | 2010-01-08 | 2011-11-28 | Sanofi Sa | Process for producing dronedarone |
IT1398317B1 (it) * | 2010-02-23 | 2013-02-22 | Chimico Internaz Spa Lab | Nuovo procedimento per la preparazione del dronedarone. |
FR2957079B1 (fr) | 2010-03-02 | 2012-07-27 | Sanofi Aventis | Procede de synthese de derives de cetobenzofurane |
EP2371824A1 (en) * | 2010-03-08 | 2011-10-05 | Ratiopharm GmbH | Crystalline dronedarone salts |
FR2958290B1 (fr) | 2010-03-30 | 2012-10-19 | Sanofi Aventis | Procede de preparation de derives de sulfonamido-benzofurane |
FR2958291B1 (fr) | 2010-04-01 | 2013-07-05 | Sanofi Aventis | Procede de preparation de derives d'amino-benzofurane |
HUP1000330A2 (en) | 2010-06-18 | 2011-12-28 | Sanofi Sa | Process for the preparation of dronedarone and the novel intermediates |
US8602215B2 (en) | 2010-06-30 | 2013-12-10 | Sanofi | Methods for reducing the risk of an adverse dronedarone/beta-blockers interaction in a patient suffering from atrial fibrillation |
WO2012004658A2 (en) | 2010-07-09 | 2012-01-12 | Frichem Private Limited | Process for preparation of n-[2-butyl-3-[4-[3-(dibutylamino)propoxy]benzoyl]-5-benzofuranyl]methanesulfonamide, acid addition salts and product thereof |
WO2012007959A1 (en) * | 2010-07-16 | 2012-01-19 | Glenmark Generics Limited | Process for preparing dronedarone |
FR2962731B1 (fr) | 2010-07-19 | 2012-08-17 | Sanofi Aventis | Procede de preparation de derives d'amino-benzoyl-benzofurane |
FR2963006B1 (fr) | 2010-07-21 | 2013-03-15 | Sanofi Aventis | Procede de preparation de derives de nitro-benzofurane |
HUP1000386A2 (en) | 2010-07-22 | 2012-05-29 | Sanofi Sa | Novel process for producing dronedarone |
WO2012032545A1 (en) * | 2010-09-08 | 2012-03-15 | Cadila Healthcare Limited | Processes for preparing dronedarone and its intermediates |
EP2447256A1 (en) * | 2010-10-21 | 2012-05-02 | Laboratorios Lesvi, S.L. | Process for obtaining dronedarone |
CN102070581B (zh) * | 2011-01-19 | 2015-11-25 | 上海医药工业研究院 | 2-正丁基-3-(4-(3-二正丁基氨基丙氧基)苯甲酰基)-5-氨基苯并呋喃的制备 |
CN102070578B (zh) * | 2011-01-19 | 2015-10-14 | 上海医药工业研究院 | 2-正丁基-3-(4-(3-二正丁基氨基丙氧基)苯甲酰基)-5-烷酰基氨基苯并呋喃的制备方法 |
CN102070580B (zh) * | 2011-01-19 | 2015-05-20 | 上海医药工业研究院 | 2-正丁基-3-(4-(3-二正丁基氨基丙氧基)苯甲酰基)-5-取代氨基苯并呋喃的制备 |
CN102070579B (zh) * | 2011-01-19 | 2016-03-09 | 上海医药工业研究院 | 2-正丁基-3-(4-取代丙氧基苯甲酰基)-5-取代氨基苯并呋喃的制备方法 |
WO2012120544A2 (en) | 2011-03-10 | 2012-09-13 | Sun Pharmaceutical Industries Ltd. | PROCESS FOR N-[2-n-BUTYL-3-[4-[3-(DI-n-BUTYLAMINO) PROPOXY]ENZOYL]BENZOFURAN-5-YL]METHANESULFONAMIDE HYDROCHLORIDE |
CN102690249B (zh) * | 2011-03-22 | 2014-09-17 | 江苏康缘药业股份有限公司 | 一种决奈达隆的制备方法 |
HUP1100166A2 (en) | 2011-03-29 | 2012-12-28 | Sanofi Sa | Reductive amination process for preparation of dronedarone using amine intermediary compound |
HUP1100165A2 (en) | 2011-03-29 | 2012-12-28 | Sanofi Sa | Process for preparation of dronedarone by n-butylation |
HUP1100167A2 (en) * | 2011-03-29 | 2012-11-28 | Sanofi Sa | Process for preparation of dronedarone by mesylation |
WO2013014480A1 (en) | 2011-07-26 | 2013-01-31 | Sanofi | Process for preparation of dronedarone using amide intermediary compound |
WO2013014479A1 (en) | 2011-07-26 | 2013-01-31 | Sanofi | Reductive animation process for preparation of dronedarone using aldehyde intermediary compound |
WO2013014478A1 (en) | 2011-07-26 | 2013-01-31 | Sanofi | Reductive amination process for preparation of dronedarone using carboxyl intermediary compound |
ITMI20111672A1 (it) * | 2011-09-16 | 2013-03-17 | Olon Spa | Metodo efficiente per la preparazione di dronedarone cloridrato |
FR2983198B1 (fr) | 2011-11-29 | 2013-11-15 | Sanofi Sa | Procede de preparation de derives de 5-amino-benzoyl-benzofurane |
EP2617718A1 (en) | 2012-01-20 | 2013-07-24 | Sanofi | Process for preparation of dronedarone by the use of dibutylaminopropanol reagent |
US9221778B2 (en) | 2012-02-13 | 2015-12-29 | Sanofi | Process for preparation of dronedarone by removal of hydroxyl group |
US9249119B2 (en) | 2012-02-14 | 2016-02-02 | Sanofi | Process for the preparation of dronedarone by oxidation of a sulphenyl group |
WO2013124745A1 (en) | 2012-02-22 | 2013-08-29 | Sanofi | Process for preparation of dronedarone by oxidation of a hydroxyl group |
US9238636B2 (en) | 2012-05-31 | 2016-01-19 | Sanofi | Process for preparation of dronedarone by Grignard reaction |
CN102675267B (zh) * | 2012-06-07 | 2015-05-13 | 济南富创医药科技有限公司 | 盐酸决奈达隆及其中间体的制备方法 |
CN108164411B (zh) * | 2017-12-29 | 2021-03-02 | 苏州汶颢微流控技术股份有限公司 | 基于微反应器制备对庚氧基苯甲酸的方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3947470A (en) * | 1974-06-20 | 1976-03-30 | Smithkline Corporation | Substituted benzofurans and benzothiophenes |
US4024273A (en) * | 1974-06-20 | 1977-05-17 | Smithkline Corporation | Coronary vasodilator and anti-anginal compositions comprising substituted benzofurans and benzothiophenes and methods of producing coronary vasodilation and anti-anginal activity |
FR2665444B1 (fr) * | 1990-08-06 | 1992-11-27 | Sanofi Sa | Derives d'amino-benzofuranne, benzothiophene ou indole, leur procede de preparation ainsi que les compositions les contenant. |
US5731436A (en) * | 1994-08-31 | 1998-03-24 | Eli Lilly And Company | Process for preparing benzoic acid derivative intermediates and benzothiophene pharmaceutical agents |
US5631369A (en) * | 1994-08-31 | 1997-05-20 | Eli Lilly And Company | Process for preparing benzoic acid derivative intermediates and benzothiophene pharmaceutical agents |
-
2000
- 2000-12-11 FR FR0016069A patent/FR2817865B1/fr not_active Expired - Fee Related
-
2001
- 2001-12-10 US US10/433,639 patent/US6846936B2/en not_active Expired - Lifetime
- 2001-12-10 DK DK01270513T patent/DK1351907T3/da active
- 2001-12-10 AU AU2002217227A patent/AU2002217227A1/en not_active Abandoned
- 2001-12-10 ES ES01270513T patent/ES2276741T3/es not_active Expired - Lifetime
- 2001-12-10 AR ARP010105714A patent/AR035663A1/es not_active Application Discontinuation
- 2001-12-10 HU HU0500981A patent/HUP0500981A3/hu unknown
- 2001-12-10 DE DE60124587T patent/DE60124587T2/de not_active Expired - Lifetime
- 2001-12-10 MX MXPA03005223A patent/MXPA03005223A/es active IP Right Grant
- 2001-12-10 JP JP2002549615A patent/JP4437004B2/ja not_active Expired - Fee Related
- 2001-12-10 CZ CZ20031611A patent/CZ303489B6/cs not_active IP Right Cessation
- 2001-12-10 CA CA2429268A patent/CA2429268C/fr not_active Expired - Fee Related
- 2001-12-10 SK SK727-2003A patent/SK287770B6/sk not_active IP Right Cessation
- 2001-12-10 CN CNB200510108930XA patent/CN100371314C/zh not_active Expired - Fee Related
- 2001-12-10 PL PL364774A patent/PL206029B1/pl unknown
- 2001-12-10 EP EP01270513A patent/EP1351907B1/fr not_active Expired - Lifetime
- 2001-12-10 AT AT01270513T patent/ATE345319T1/de active
- 2001-12-10 WO PCT/FR2001/003900 patent/WO2002048078A1/fr active IP Right Grant
- 2001-12-10 CN CNB018203787A patent/CN1295200C/zh not_active Expired - Fee Related
- 2001-12-10 BR BRPI0116065-6A patent/BR0116065B1/pt not_active IP Right Cessation
-
2003
- 2003-06-11 HR HR20030471A patent/HRP20030471B1/xx not_active IP Right Cessation
- 2003-11-13 HK HK03108257A patent/HK1055944A1/xx not_active IP Right Cessation
-
2008
- 2008-07-11 JP JP2008181486A patent/JP2009024007A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1351907T3 (da) | 2-Butyl - 3 - (4-(3-dibutylamino) propoxy) -5- nitrobenzofuranchlorhydrat og fremstilling heraf | |
DK1202941T3 (da) | Gipssammensætninger og beslægtede fremgangsmåder | |
NO20015113D0 (no) | Nye forbindelser, deres fremstilling og anvendelse | |
NO20032893D0 (no) | Urtepreparat for angina pectoris, fremstilling og anvendelse derav | |
NO20024742D0 (no) | Heterocykliske forbindelser, deres fremstilling og anvendelse | |
NO20024874L (no) | Benzoamidpiperidin-inneholdende forbindelser og beslektede forbindelser | |
NO20022289D0 (no) | Ny anvendelse og nye N-azabisykloamidderivater | |
NO20022334L (no) | Ny sammensetning og anvendelse | |
NO20015362L (no) | Heterocyklisk substituerte benzimidazoler, deres fremstilling og anvendelse derav | |
NO20014553D0 (no) | Brönnplanlegging og konstruksjon | |
NO20025450L (no) | Ny farmasöytisk sammensetning | |
DE50112013D1 (de) | Deodorantien und antiperspirantien | |
NO20031838D0 (no) | Benzokazinonderivater, deres fremstilling og anvendelse | |
DK1043307T3 (da) | 3-amino-3-arylpropan-1-ol-derivater, deres fremstilling og anvendelse | |
NO20030882D0 (no) | Glasskeramikkmasse og anvendelse derav | |
NO20024760D0 (no) | Stabil og effektiv myk, fast antiperspirant og/eller deodorant | |
NO20013891D0 (no) | Sammensetninger omfattende citalopram | |
NO20030156D0 (no) | Farmasöytiske sammensetninger og fremgangsmåter for anvendelse derav | |
NO20025474D0 (no) | Benzofuranderivater | |
NO20012802D0 (no) | Benzofuranderivater, deres fremstilling og anvendelse | |
ATE280753T1 (de) | Hydrazid und alkoxyamid angiogeneseinhibitoren | |
NO20032821D0 (no) | Sea-trosy og beslektede fremgangsmåter | |
DK1010689T3 (da) | Substituerede cycloheptener, deres fremstilling og anvendelse | |
NO20025135L (no) | Antihypertensive midler og anvendelse | |
ITMI20000722A0 (it) | Meccanismo di sollevamento per letti e simili |